Advanced search
Publication Cover
Autophagy Volume 11, 2015 - Issue 10
Submit an article Journal homepage
2,632
Views
76
CrossRef citations to date
0
Altmetric
CLINICAL RESEARCH PAPER

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer

Sylvain LadoireDepartment of Medical Oncology, Georges François Leclerc Center; Dijon, France;Institut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France
,
Frédérique Penault-LlorcaCentre Jean Perrin, EA 4677 Clermont-Ferrand; Clermont-Ferrand, France;ERTICa; EA 4677 University of Auvergne; Clermont-Ferrand, France
,
Laura SenovillaEquipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France;Metabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif, France
,
Cécile DalbanBiostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon, France
,
David EnotMetabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif, France
,
Clara LocherInstitut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France
,
Nicole PradaInstitut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France
,
Vichnou Poirier-ColameInstitut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France
,
Kariman ChabaEquipe 11 labellisée pas la Ligue Nationale contre le Cancer; Centre de Recherche des Cordeliers; Paris, France;Université Paris Descartes; Sorbonne Paris Cité; Paris, France
,
Laurent ArnouldDepartment of Pathology and Tumor Biology; Georges François Leclerc Center; Dijon, France
,
François GhiringhelliDepartment of Medical Oncology, Georges François Leclerc Center; Dijon, France;Institut National de la Santé et de la Recherche Médicale; Avenir Team INSERM; CRI-866 University of Burgundy, Dijon, France
,
Pierre FumoleauDepartment of Medical Oncology, Georges François Leclerc Center; Dijon, France
,
Marc SpielmannDepartment of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy, Villejuif, France
,
Suzette DelalogeDepartment of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy, Villejuif, France
,
Marie Laure PoillotBiostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon, France
,
Patrick ArveuxBiostatistics and Epidemiology Unit; EA 4184; Centre Georges Francois Leclerc Dijon, France
,
Aicha GoubarINSERM U981 “Identification of molecular predictors and new targets for cancer treatment”; Institut Gustave Roussy; Villejuif, France
,
Fabrice AndreDepartment of Medical Oncology and Breast Cancer Group; Institut Gustave Roussy, Villejuif, France;INSERM U981 “Identification of molecular predictors and new targets for cancer treatment”; Institut Gustave Roussy; Villejuif, France
,
Laurence ZitvogelInstitut National de la Santé et de la Recherche Médicale; U1015, Equipe labellisée Ligue Nationale Contre le Cancer; Institut Gustave Roussy, Villejuif, France;University of Paris Sud XI, Villejuif, France;Center of Clinical Investigations in Biotherapies of Cancer (CICBT), Villejuif, FranceCorrespondence[email protected] [email protected]
&
Guido KroemerMetabolomics and Cell Biology Platforms; Gustave Roussy Cancer Campus; Villejuif, France;Pôle de Biologie; Hôpital Européen Georges Pompidou; Assistance Publique-Hôpitaux de Paris; Paris, France;INSERM; U1138, Paris, FranceCorrespondence[email protected] [email protected]
 show all
Pages 1878-1890 | Received 27 Oct 2014, Accepted 07 Aug 2015, Published online: 27 Oct 2015

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
Source: Figshare
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
Source: Figshare
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
Source: Figshare

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.